Albornoz EA, Woodruff TM, Gordon R. Inflammasomes in CNS diseases. Exp Suppl. 2018;108:41–60.

CAS  PubMed  Google Scholar 

Voet S, Srinivasan S, Lamkanfi M, van Loo G. Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med. 2019;11:e10248.

Article  PubMed  PubMed Central  Google Scholar 

Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10:417–26.

Article  CAS  PubMed  Google Scholar 

Gordon R, Albornoz EA, Christie DC, Langley MR, Kumar V, Mantovani S, et al. Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med. 2018;10:eaah4066.

Article  PubMed  PubMed Central  Google Scholar 

Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature. 2013;493:674–8.

Article  CAS  PubMed  Google Scholar 

Deora V, Lee JD, Albornoz EA, McAlary L, Jagaraj CJ, Robertson AAB, et al. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia. 2020;68:407–21.

Article  PubMed  Google Scholar 

Kaushik DK, Gupta M, Kumawat KL, Basu A. NLRP3 inflammasome: key mediator of neuroinflammation in murine Japanese encephalitis. PLoS One. 2012;7:e32270.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang W, Li G, De W, Luo Z, Pan P, Tian M, et al. Zika virus infection induces host inflammatory responses by facilitating NLRP3 inflammasome assembly and interleukin-1beta secretion. Nat Commun. 2018;9:106.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferini-Strambi L, Salsone M. COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? J Neurol. 2021;268:409–19.

Article  CAS  PubMed  Google Scholar 

Liu J, Li Y, Liu Q, Yao Q, Wang X, Zhang H, et al. SARS-CoV-2 cell tropism and multiorgan infection. Cell Disco. 2021;7:17.

Article  CAS  Google Scholar 

Puelles VG, Lutgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, et al. Multiorgan and renal tropism of SARS-CoV-2. N. Engl J Med. 2020;383:590–2.

Article  PubMed  Google Scholar 

Thakur KT, Miller EH, Glendinning MD, Al-Dalahmah O, Banu MA, Boehme AK, et al. COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain. 2021;144:2696–2708.

Article  PubMed  PubMed Central  Google Scholar 

Matschke J, Lutgehetmann M, Hagel C, Sperhake JP, Schroder AS, Edler C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19:919–29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seehusen F, Clark JJ, Sharma P, Bentley EG, Kirby A, Subramaniam K, et al. Neuroinvasion and neurotropism by SARS-CoV-2 variants in the K18-hACE2 mouse. Viruses. 2022;14:1020.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaufer C, Schreiber CS, Hartke AS, Denden I, Stanelle-Bertram S, Beck S, et al. Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model. EBioMedicine. 2022;79:103999.

Article  PubMed  PubMed Central  Google Scholar 

Rutkai I, Mayer MG, Hellmers LM, Ning B, Huang Z, Monjure CJ, et al. Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat Commun. 2022;13:1745.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Merello M, Bhatia KP, Obeso JA. SARS-CoV-2 and the risk of Parkinson’s disease: facts and fantasy. Lancet Neurol. 2021;20:94–95.

Article  CAS  PubMed  Google Scholar 

Najjar S, Najjar A, Chong DJ, Pramanik BK, Kirsch C, Kuzniecky RI, et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation. 2020;17:231.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen AK, Wang X, McCluskey LP, Morgan JC, Switzer JA, Mehta R, et al. Neuropsychiatric sequelae of long COVID-19: Pilot results from the COVID-19 neurological and molecular prospective cohort study in Georgia. Usa Brain Behav Immun Health. 2022;24:100491.

Article  CAS  PubMed  Google Scholar 

Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416–27.

Article  PubMed  PubMed Central  Google Scholar 

Siderowf A, Jennings D, Eberly S, Oakes D, Hawkins KA, Ascherio A, et al. Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study. Mov Disord. 2012;27:406–12.

Article  PubMed  PubMed Central  Google Scholar 

Cohen ME, Eichel R, Steiner-Birmanns B, Janah A, Ioshpa M, Bar-Shalom R, et al. A case of probable Parkinson’s disease after SARS-CoV-2 infection. Lancet Neurol. 2020;19:804–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mendez-Guerrero A, Laespada-Garcia MI, Gomez-Grande A, Ruiz-Ortiz M, Blanco-Palmero VA, Azcarate-Diaz FJ, et al. Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology. 2020;95:e2109–e2118.

Article  CAS  PubMed  Google Scholar 

Faber I, Brandao PRP, Menegatti F, de Carvalho Bispo DD, Maluf FB, Cardoso F. Coronavirus disease 2019 and Parkinsonism: a non-post-encephalitic case. Mov Disord. 2020;35:1721–2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pavel A, Murray DK, Stoessl AJ. COVID-19 and selective vulnerability to Parkinson’s disease. Lancet Neurol. 2020;19:719.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brundin P, Nath A, Beckham JD. Is COVID-19 a perfect storm for Parkinson’s disease? Trends Neurosci. 2020;43:931–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bao L, Deng W, Huang B, Gao H, Liu J, Ren L, et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. 2020;583:830–3.

Article  CAS  PubMed  Google Scholar 

Isaacs A, Amarilla AA, Aguado J, Modhiran N, Albornoz EA, Baradar AA, et al. Nucleocapsid specific diagnostics for the detection of divergent SARS-CoV-2 variants. Front Immunol. 2022;13:926262.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li XX, Clark RJ, Woodruff TM. C5aR2 activation broadly modulates the signaling and function of primary human macrophages. J Immunol. 2020;205:1102–12.

Article  CAS  PubMed  Google Scholar 

Deora V, Albornoz EA, Zhu K, Woodruff TM, Gordon R. The ketone body beta-hydroxybutyrate does not inhibit synuclein mediated inflammasome activation in microglia. J Neuroimmune Pharm. 2017;12:568–74.

Article  Google Scholar 

Amarilla AA, Sng JDJ, Parry R, Deerain JM, Potter JR, Setoh YX, et al. A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses. Nat Commun. 2021;12:3431.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grubaugh ND, Gangavarapu K, Quick J, Matteson NL, De Jesus JG, Main BJ, et al. An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar. Genome Biol. 2019;20:8.

Article  PubMed  PubMed Central  Google Scholar 

Amarilla AA, Modhiran N, Setoh YX, Peng NYG, Sng JDJ, Liang B, et al. An optimized high-throughput immuno-plaque assay for SARS-CoV-2. Front Microbiol. 2021;12:625136.

Article  PubMed  PubMed Central  Google Scholar 

CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel. https://www.cdc.gov/coronavirus/2019-ncov/lab/virus-requests.html, 2021, Accessed Date.

Conceicao C, Thakur N, Human S, Kelly JT, Logan L, Bialy D, et al. The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins. PLoS Biol. 2020;18:e3001016.

Article  CAS  PubMed  PubMed Central